Moneycontrol
    Moneycontrol PRO
    LAMF
    LAMF

    At Moneycontrol, the Results page helps you effectively track corporate announcements and results for various listed companies across both India and abroad. With our Results page, you can keep abreast with an updated, comprehensive view of all the profit/loss statements, company spendings, AGM outcomes, and quarterly and annual results from all these listed companies. Additionally, Moneycontrol also regularly tracks international MNCs listed on NASDAQ and Asian bourses, including popular companies like Apple, Google, Alibaba. Apart from finding solid copies of company results, stock movements consequent to these company results, expectations, and analytical post results copies, you will also find copies and articles detailing the earnings, impact, and all major announcements made to media/exchanges by these companies, so that you do not miss anything. We also provide you with concrete data points to help you spot profitable trades, stock build-ups, and bulk deals. At Moneycontrol, we also cover analysts/investors meetings; scrutinise results and data and BSE/NSE reports or news. The copies are not just full of information and data, but are also adequately supplemented with expert views, investor opinions, extensive interviews, videos, and a huge variety of explainers, analyses, and informative slideshows to help you gauge the market and make investment decisions in the best possible manner. More

    Jump to

    • Apollo Hospitals Q3 Preview: Better occupancy, higher ARPOBs to drive earnings growth in seasonally weak quarter

      Apollo Hospitals' efforts to ramp-up occupancy levels and average revenue per occupied bed is expected to drive solid earnings growth in Q3, which usually remains a seasonally weak quarter for hospital majors.

    • Apollo Hospitals Q4 preview: Steady hospital business, healthy growth in HealthCo to aid earnings expansion

      Improved performance from Apollo Hospitals' online business, Apollo HealthCo, and strong seasonality for its flagship hospital business is expected to drive earnings growth in Q4.

    • Apollo Hospitals Q1 Preview: Losses from Apollo HealthCo to drag earnings

      While losses in the company's Apollo HealthCo arm are likely to moderate sequentially, they will still remain elevated on the year-on-year basis.

    • Apollo Hospitals Q1 PAT seen up 1.5% YoY to Rs. 246.76 cr: ICICI Direct

    • Apollo Hospitals Enterprise Q1 PAT may dip 14.2% YoY to Rs 167.4 cr: Prabhudas Lilladher

    • Apollo Hospitals Q4 PAT seen up 43.4% YoY to Rs. 215.66 cr: ICICI Direct

    • Apollo Hospitals Q3 PAT seen up 100.7% YoY to Rs. 261.8 cr: ICICI Direct

    • Apollo Hospitals Q1 PAT may dip 167.4% YoY to Rs 140.2 cr: ICICI Direct

    • Apollo Hospitals Q2 PAT seen up 111.5% YoY to Rs. 130.9 cr: Kotak

    • Apollo Hospitals Q1 PAT seen up 170.7% YoY to Rs. 95 cr: Kotak

    • Apollo Hospitals Q4 PAT seen up 45.7% YoY to Rs. 52 cr: Kotak

    • Apollo Hospitals Q3 PAT seen up 38.4% YoY to Rs. 93.3 cr: ICICI Direct

    • Apollo Hospitals Q2 PAT seen up 37.4% YoY to Rs. 97.4 cr: ICICI Direct

    • Apollo Hospitals Q4 PAT seen up 47.8% YoY to Rs 71.2 cr: Edelweiss

    • Aim to have close to 3000 pharmacies by end of this year: Apollo Hospital

    • Occupancies for hospital biz at 68%; mature hospital occupancy at 71%: Apollo Hospitals

    • Apollo Hospitals Q2 PAT may dip 53% YoY to Rs. 30 cr: Kotak

    • Added 150 beds in Navi Mumbai unit; 100 occupied currently: Apollo Hospitals

    • Will not raise more debt, not looking at acquisition currently: Apollo Hospitals

    • Apollo Hospitals upbeat on Q4; sees EBITDA margins around 12%

    • Focus on restructuring to ensure growth of all verticals: Apollo

    • Apollo Hospitals Q1 PAT seen down 8.8% to Rs 69 cr: Edelweiss

    • Pharmacy sales to grow at 25%; eye acquisitions: Apollo Hospital

    • See pharmacy growing at 25-30% going forward: Apollo Hospitals

    • Apollo Hospitals Q3 profit seen up 1.9%, revenue may rise 26%

    Advisory Alert:

    It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347